Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils

Brain Research

Volumn 853, Issue 2, 2000, Pages 344-351

  Ray, Indrani ^a   Chauhan, Abha ^a   Wegiel, Jerzy ^a   Chauhan, Ved P S ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; Amyloid beta protein; Cerebrospinal fluid; Fibrillization; Gelsolin; Plasma

Indexed keywords

AMYLOID BETA PROTEIN; CONGO RED; GELSOLIN;

AGING; ALZHEIMER DISEASE; ARTICLE; DOSE TIME EFFECT RELATION; ELECTRON MICROSCOPY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMYLOID BETA-PROTEIN; ANIMALS; BIOPOLYMERS; CATTLE; CONGO RED; GELSOLIN; MICROSCOPY, ELECTRON; NEGATIVE STAINING; NEUROFIBRILS; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 0033988752     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02315-X     Document Type: Article

References (31)

1. Biere A.L., Ostaszewski B., Stimson E.R., Hyman B.T., Maggie J.E., Selkoe D.J. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271:1996;32916-32922.
2. Chauhan A., Chauhan V.P.S., Rubenstein R., Wegiel J., Wisniewski H.M. Media from rhabdomyosarcoma and neuroblastoma cell cultures stimulate in vitro aggregation and fibrillization of amyloid beta-protein. Neurochem. Res. 22:1997;227-232.
3. Chauhan A., Chauhan V.P.S., Wegiel J., Wisniewski H.M. Impact of normal and heat-inactivated serum on in vitro aggregation and fibrillization of synthetic amyloid beta-protein. Alzheimer's Res. 2:1996;243-248.
4. Chauhan V.P.S., Ray I., Chauhan A., Wegiel J., Wisniewski H.M. Metal cations defibrillize the amyloid beta-protein fibrils. Neurochem. Res. 22:1997;805-809.
5. Chauhan V.P.S., Ray I., Chauhan A., Wisniewski H.M. Binding of gelsolin, a secretory protein, to amyloid beta-protein. Biochem. Biophys. Res. Commun. 258:1999;241-246.
6. Furukawa K., Fu W., Li Y., Witke W., Kwiatkowski D.J., Mattson M.P. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17:1997;8178-8186.
7. Ghiso J., Matsubara E., Koudinov A., Wisniewski T., Frangione B. The cerebrospinal fluid soluble form of Alzheimer's amyloid β is complexed to SP-40, 40 (APO J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293:1993;27-30.
8. Haas C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;325-327.
9. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;403-407.
10. Hilbich C., Kisters-Woike B., Reed J., Masters C.L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J. Mol. Biol. 218:1991;149-163.
11. Janney P.A., Chapannier C., Lind S.E., Zaner K.S., Stossel T.P., Yin H.L. Interactions of gelsolin and gelsolin-actin complexes with actin. Effects of calcium on actin nucleation, filament severing, and end blocking. Biochemistry. 24:1985;3714-3723.
12. Jarrett J.T., Lansbury P.T. Jr. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry. 31:1992;12345-12352.
13. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., McGarry T.J., Kirschner M.W., Koths K., Kwiatkowski D.J., Williams L.T. Caspase-3-generated fragment of gelsolin: effector of morphological changes in apoptosis. Science. 278:1997;294-298.
14. Koudinov A., Matsubara E., Frangione B., Ghiso J. The soluble form of Alzheimer's amyloid beta-protein is complexed to high-density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem. Biophys. Res. Commun. 205:1994;1164-1171.
15. Kuzumaki N., Tanaka M., Sakai N., Fujita H. Tumor suppressive function of gelsolin. Gan To Kagaku Royoho. 24:1997;1436-1441.
16. Lorenzo A., Yankner B.A. β-Amyloid neurotoxicity requires fibril formation. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12243-12247.
17. Ma J., Yee A., Brewer H.B. Jr., Das S., Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 372:1994;92-94.
18. Paunio T., Kiuru S., Karonen S.-L., Palo J., Peltonen L. Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel), Amyloid. Int. J. Exp. Clin. Invest. 1:1994;80-89.
19. Schwarzman A.L., Gregori L., Vitek M.P., Lyubski S., Strittmatter W.J., Enghilde J.J., Bhasin R., Silverman J., Weisgraber K.H., Coyle P.K., Zagorski M.G., Talafous J., Eisenberg M., Saunders A.M., Roses A.D., Goldgaber D. Transthyretin sequesters amyloid β-protein and prevents amyloid formation. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8368-8371.
20. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehyurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantitation of soluble Alzheimer's beta-peptide from biological fluids. Nature. 359:1992;325-327.
21. Simmons L.K., May P.C., Tomasseli K.J., Rydel R.E., Fuson K.S., Brigham E.F., Wright S., Lieberburg I., Becker G.W., Brems D.N., Li W.Y. Secondary structure of amyloid β-peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45:1994;373-379.
22. T.P. Stossel, Actin-membrane interactions in eukaryotic mammalian cells, in: J.F. Hoffman, G. Giebisch (Eds.), Current Topics in Membranes and Transport, Vol. 36, Academic Press, NY, 1990, pp. 97-107.
23. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Increased frequency of type 4 allele in late-onset familial Alzheimer disease. Apolipoprotein E: High-avidity binding to beta-amyloid. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1977-1981.
24. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.-M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid β-peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8098-8102.
25. Tanaka J., Sobue K. Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J. Neurosci. 14:1994;1038-1052.
26. Vigo-Pelfrey C., Lee D., Keim P., Lieberburg I., Schenk D.B. Characterization of β-amyloid peptide from human cerebrospinal fluid. J. Neurochem. 61:1993;1965-1968.
27. Wegiel J., Chauhan A., Wisniewski H.M., Nowakowski J., Wang K.C., Levine H. Promotion of synthetic amyloid β-peptide fibrillization by cell culture media and abolishment of fibrillization by serum. Neurosci. Lett. 211:1996;151-154.
28. Wisniewski T., Castano E.M., Golabek A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145:1994;1030-1035.
29. Wisniewski T., Ghiso J., Frangione B. Alzheimer's disease and soluble Aβ Neurobiol. Aging. 15:1994;143-152.
30. Wisniewski T., Ghiso J., Frangione B. Biology of Aβ amyloid in Alzheimer's disease. Neurobiol. Dis. 4:1997;313-328.
31. Younkin S.G. Evidence that Aβ 42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37:1995;287-288.